What should I do for oral bleeding while taking Eliquis (apixaban)?

Management of Oral Bleeding While Taking Eliquis (Apixaban)

For minor oral bleeding (bleeding gums, small mouth cuts) while on Eliquis, continue your medication and apply local measures including direct pressure with gauze soaked in tranexamic acid if available, ice application, and avoid disturbing the clot—most oral bleeding is non-major and does not require stopping anticoagulation. 1

Determining Bleeding Severity

The 2020 ACC Expert Consensus Decision Pathway provides a clear framework for assessing whether your oral bleeding is major or non-major 1:

Your bleeding is considered MAJOR if ANY of the following apply:

• Bleeding at a critical site (intracranial, intraspinal, intraocular, pericardial, intra-articular, intramuscular with compartment syndrome, or retroperitoneal)
• Hemodynamic instability (dizziness, lightheadedness, rapid heart rate, low blood pressure)
• Hemoglobin decrease ≥2 g/dL or requiring ≥2 units of blood transfusion

Your bleeding is NON-MAJOR if:

• None of the above criteria are met
• This includes most oral bleeding episodes like bleeding gums, minor tongue/cheek bites, or bleeding after dental procedures

Management Based on Severity

For Non-Major Oral Bleeding (Most Common Scenario)

Continue Eliquis and implement local hemostatic measures 1:

• Apply direct pressure with gauze for 10-20 minutes without checking
• Use ice applied to the bleeding site
• Tranexamic acid mouthwash (if available): swish and spit 10 mL of 5% solution four times daily
• Avoid disturbing the clot: no hot liquids, no straws, soft diet for 24-48 hours
• Assess for contributing factors: thrombocytopenia, uremia, liver disease, concurrent antiplatelet agents (aspirin, NSAIDs)
• Verify correct Eliquis dosing: Standard dose is 5 mg twice daily; 2.5 mg twice daily only if you meet ≥2 of these criteria: age ≥80 years, weight ≤60 kg, or serum creatinine ≥1.5 mg/dL

Common pitfall: Do NOT stop Eliquis for minor oral bleeding, as this increases your stroke/clot risk without meaningful benefit 2.

For Major Oral Bleeding (Rare but Serious)

If you experience uncontrolled bleeding that soaks through multiple gauze pads, causes dizziness/weakness, or doesn't stop after 30 minutes of pressure, this requires emergency evaluation 1:

1. Stop Eliquis immediately
2. Call 911 or go to the emergency department
3. Continue local pressure while seeking help
4. Hospital management will include:
   • Supportive care and volume resuscitation
   • Local hemostatic measures
   • Andexanet alfa (specific reversal agent for apixaban) if life-threatening 1, 3
     • Low dose: 400 mg IV bolus + 4 mg/min infusion for 2 hours if last dose taken ≥8 hours ago or dose ≤5 mg taken <8 hours ago
     • High dose: 800 mg IV bolus + 8 mg/min infusion for 2 hours if dose >5 mg taken <8 hours ago
   • Alternative: 4-factor prothrombin complex concentrate if andexanet unavailable

Special Considerations for Dental Procedures

For planned dental extractions or procedures 4:

• Simple procedures (1-3 teeth, no flap elevation): Continue Eliquis—bleeding risk is manageable with local measures
• Complex procedures (>3 teeth, flap elevation, osteotomy): Consider holding Eliquis for 24-48 hours before procedure (discuss with prescribing physician)
• Post-procedure bleeding is more common with apixaban but typically mild and controllable with pressure and tranexamic acid mouthwash

Risk Factors That Increase Bleeding

Be particularly vigilant if you have 5:

• Concurrent NSAID use (ibuprofen, naproxen)—increases bleeding risk 10-fold
• Active cancer—increases risk 2.9-fold
• Age >80 years
• Low albumin levels (<3.5 g/dL)—increases free drug concentration 6
• Kidney impairment—prolongs drug half-life (6-15 hours normally, up to 17 hours with severe kidney disease) 1

When to Restart Eliquis After Major Bleeding

Once bleeding is controlled, restart Eliquis within 7-14 days unless 1:

• Bleeding occurred at a critical site
• High risk of rebleeding or death/disability with rebleeding
• Source of bleeding not identified
• Surgical procedures planned
• Patient preference after shared decision-making

The stroke/clot risk from stopping anticoagulation typically outweighs bleeding risk after initial control is achieved 2.

Key Takeaway

Most oral bleeding on Eliquis is minor, manageable with local pressure and ice, and does not require stopping your medication. The FDA label explicitly warns that stopping Eliquis increases stroke risk 2. Only stop for uncontrolled major bleeding requiring emergency care, where reversal with andexanet alfa may be indicated 3. Always discuss any bleeding concerns with your prescribing physician before making changes to your anticoagulation regimen.